CELF2 and hepatocellular carcinoma: Furthermore, we showed that CRNDE targeted directly at EZH2, SUZ12, and SUV39H1 in HCC and promoted HCC progression by mediating their inhibition on various tumor suppressor genes, including CELF2 and LATS2.